Skip to main content

Cost-effective reimbursement analysis for medical technologies in Europe

Procedure coding, payment mechanism, reimbursement tariffs, policy, and HTA considerations in 34 EU countries

Learn more
See details

Reimbursement summary for angioplasty of arteries of lower extremities

This post presents an extract from our reimbursement analysis for angioplasty of arteries lower extremities using plain and drug-coated balloons (DCBs) for peripheral artery disease in England, France and Germany. Plain balloon angioplasty is reimbursement via DRG solely and DCBs are reimbursement via combination of DRG and add-on reimbursement.
See details

€130 million allocated to launch of the Personalized Digital Care Plan in Spain

03 Nov 2023

On October 20, 2023, the Spanish Ministry of Health announced that a budget of 130 million euros was allocated to support the upcoming launch of the Personalized Digital Care Plan. The plan, in collaboration with the autonomous communities, will allow the launch of UNICAS Network (network of personalized services for pediatric rare disease patients and their families) for the provision of personalized services to patients with rare pediatric diseases. The data usage that helps expand knowledge, reinforce prevention, improve diagnosis, expand treatments, and offer a better quality of life to patients and families will be promoted.

Healthcare digitalization, as well as the commitment to digital technologies, is already a well-established reality materialized into the Digital Health Strategy with more than 800 million euros budget allocated since 2021, based on learning regarding the importance of data in public health decision-making from the COVID-19 pandemic.

The full details in Spanish can be found here.

This news is just one of about 300 market access news collected by our team in the subscription services "HTA Alerts" and "Reimbursement Alerts" every two weeks from more than 80 organizations. Access our paid subscription services to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news). Contact us to get a free, three-month, no-obligation trial.